Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2013 by Halozyme Therapeutics.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Halozyme Therapeutics Identifier:
First received: October 13, 2011
Last updated: September 25, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)